Growth characteristics of the chimeric Japanese encephalitis virus vaccine candidate, ChimeriVax™-JE (YF/JE SA14-14-2), in Culex tritaeniorhynchus, Aedes albopictus, and Aedes aegypti mosquitoes

American Journal of Tropical Medicine and Hygiene

Volumn 62, Issue 4, 2000, Pages 480-484

  Bhatt, T R ^a   Crabtree, M B ^a   Guirakhoo, F ^a   Monath, T P ^a   Miller, B R ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIVAX; VIRUS VACCINE;

AEDES AEGYPTI; AEDES ALBOPICTUS; ARTICLE; CULEX; INOCULATION; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; VIRUS INFECTIVITY; VIRUS REPLICATION;

AEDES AEGYPTI; AEDES ALBOPICTUS; ARACHNIDA; CULEX TRITAENIORHYNCHUS; HEXAPODA; JAPANESE ENCEPHALITIS VIRUS; PRIMATES; YELLOW FEVER VIRUS (STRAIN 17D);

EID: 0034469948     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2000.62.480     Document Type: Article

References (23)

1. Epidemiology and control of Japanese encephalitis
2. Japanese encephalitis
3. The natural history of Japanese encephalitis virus
4. Vectors of Japanese encephalitis virus (JEV): Species complexes of the vectors
5. Ecologic studies of Japanese encephalitis virus in Japan, II. Mosquito infection
6. Recent changes in prevalence pattern of Japanese encephalitis virus in Hyogo Prefecture, Japan, using a two-dimensional distribution of IgG and IgM class antibody levels in swine sera
7. Prevalence of Japanese encephalitis virus infection in pigs in parts of Southern India
8. Intense transmission of Japanese encephalitis virus to pigs in a region free of epidemic encephalitis
9. Japanese encephalitis vaccines
10. Australian case-control study of adverse reactions to Japanese encephalitis vaccine
11. Neurological complications to vaccination against Japanese encephalitis
12. Immunogenicity of live attenuated SA14-14-2 Japanese encephalitis vaccine - A comparison of 1 and 3 month immunization schedules
13. Yellow fever/Japanese encephalitis chimeric viruses: Construction and biological properties
14. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax™-JE) as a live, attenuated vaccine candidate against Japanese encephalitis
15. Recombinant, chimaeric, live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and non structural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates
16. Developpement de souches sauvages et vaccinales du virus de la fievre jaune dans les cellules de Aedes aegypti et transmission au souriceau
17. Failure of Aedes aegypti to transmit yellow fever cultured virus (17D)
18. Replication, tissue tropisms and transmission of yellow fever virus in Aedes albopictus
19. The use of mosquitoes to detect and propagate dengue virus
20. Susceptibility of three laboratory strains of Aedes albopictus (Diptera: Culicidae) to Japanese encephalitis virus from Taiwan
21. Japanese encephalitis vaccine (2-8 strain) and parent (SA14 strain) in Culex tritaeniorhynchus mosquitoes
22. Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14